Project Details
Description
A Phase II randomized, double-blind, placebo controlled study to assess safety, toerability and effect on tumor size of MCS110 in patients with pigmented villonodular synovitis (PVNS)
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/11 → 4/30/19 |
Funding
- NOVARTIS PHARMA AG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.